Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.36 AUD | -1.37% |
|
-2.70% | -12.20% |
Valuation
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 35.26 | 78.22 | 58.18 | 112.4 | 79.84 | 69.06 |
Enterprise Value (EV) 1 | 32.35 | 66.98 | 38.24 | 96.74 | 69.32 | 44.8 |
P/E ratio | -5.82 x | -10.3 x | -8.75 x | -12.2 x | -8.62 x | -10.9 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 56.9 x | 82.7 x | 80.9 x | 110 x | 52.1 x | 16.3 x |
EV / Revenue | 52.2 x | 70.8 x | 53.1 x | 95 x | 45.3 x | 10.6 x |
EV / EBITDA | -4.13 x | -8.07 x | -4.29 x | -8.56 x | -6.14 x | -4.51 x |
EV / FCF | -7.72 x | -18.2 x | -7.73 x | -31.9 x | -2.72 x | 2.83 x |
FCF Yield | -13% | -5.49% | -12.9% | -3.14% | -36.8% | 35.3% |
Price to Book | 14.9 x | 7.29 x | 2.78 x | 6.66 x | 8.06 x | 11.2 x |
Nbr of stocks (in thousands) | 110,178 | 153,367 | 184,699 | 190,584 | 197,128 | 197,303 |
Reference price 2 | 0.3200 | 0.5100 | 0.3150 | 0.5900 | 0.4050 | 0.3500 |
Announcement Date | 8/31/18 | 8/30/19 | 8/31/20 | 8/27/21 | 8/30/22 | 8/31/23 |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 0.6192 | 0.9457 | 0.7195 | 1.018 | 1.532 | 4.243 |
EBITDA 1 | -7.839 | -8.298 | -8.911 | -11.3 | -11.3 | -9.925 |
EBIT 1 | -8.032 | -8.516 | -9.172 | -11.63 | -11.52 | -10.28 |
Operating Margin | -1,297.18% | -900.57% | -1,274.73% | -1,142.59% | -752.21% | -242.28% |
Earnings before Tax (EBT) 1 | -8.009 | -8.38 | -9.056 | -11.43 | -11.25 | -9.411 |
Net income 1 | -5.757 | -5.852 | -6.151 | -9.037 | -9.107 | -6.248 |
Net margin | -929.8% | -618.85% | -854.88% | -887.76% | -594.53% | -147.26% |
EPS 2 | -0.0550 | -0.0494 | -0.0360 | -0.0484 | -0.0470 | -0.0320 |
Free Cash Flow 1 | -4.192 | -3.676 | -4.945 | -3.037 | -25.51 | 15.84 |
FCF margin | -676.99% | -388.71% | -687.19% | -298.32% | -1,665.27% | 373.22% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 8/31/18 | 8/30/19 | 8/31/20 | 8/27/21 | 8/30/22 | 8/31/23 |
Balance Sheet Analysis
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 2.91 | 11.2 | 19.9 | 15.7 | 10.5 | 24.3 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -4.19 | -3.68 | -4.94 | -3.04 | -25.5 | 15.8 |
ROE (net income / shareholders' equity) | -163% | -89.4% | -38.9% | -47.8% | -68% | -77.8% |
ROA (Net income/ Total Assets) | -81% | -56.5% | -31.2% | -34.2% | -25.2% | -19% |
Assets 1 | 7.104 | 10.35 | 19.73 | 26.42 | 36.18 | 32.82 |
Book Value Per Share 2 | 0.0200 | 0.0700 | 0.1100 | 0.0900 | 0.0500 | 0.0300 |
Cash Flow per Share 2 | 0.0300 | 0.0700 | 0.1100 | 0.0900 | 0.0600 | 0.1300 |
Capex 1 | 0.09 | 0.01 | 0.01 | 0.15 | 0.52 | 0.61 |
Capex / Sales | 14.08% | 1.5% | 1.01% | 15.02% | 33.77% | 14.46% |
Announcement Date | 8/31/18 | 8/30/19 | 8/31/20 | 8/27/21 | 8/30/22 | 8/31/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.20% | 50.02M | |
+5.16% | 212B | |
+9.62% | 188B | |
+31.18% | 157B | |
+33.37% | 114B | |
+3.46% | 64.01B | |
+1.51% | 48.83B | |
-4.27% | 39.3B | |
+0.88% | 35.97B | |
+8.44% | 27B |
- Stock Market
- Equities
- OCC Stock
- Financials Orthocell Limited